Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- 2018
- Published
AIRR Data Under the E.U. Trade Secrets Directive: Aligning Scientific Practices with Commercial Realities
Sherkow, J. S. & Minssen, Timo, 14 Sep 2018, Social Science Research Network (SSRN), 23 p.Research output: Working paper › Research
- Published
Research- & Bolar exemptions in the U.S. and Europe: Recent developments and possible scenarios: Report on CeBIL webinar III in the webinar series on "Reinterpreting TRIPS in the Life Sciences"
Wested, Jakob & Minssen, Timo, 15 Jul 2018, Social Science Research Network (SSRN). 11 p.Research output: Book/Report › Report › Research
- Published
Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?
Wested, Jakob, Minssen, Timo & Van Zimmeren, E., 13 Jul 2018, In: Life Sciences Intellectual Property Review (LSIPR). 13/7 2018, 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Response to Nuffield Council on Bioethics’ Genome editing and human reproduction: open call for evidence
Nordberg, A., Minssen, Timo, de Miguel Beriain, I., Wartiovaara, K., Galvagni, L. & Feeney, O., 1 Jul 2018, 2 p. Nuffield Council on Bioethics.Research output: Other contribution › Net publication - Internet publication › Research › peer-review
- Published
Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?
Wested, Jakob, Minssen, Timo & Van Zimmeren, E., Jul 2018, Harvard Law School's Bill of Health blog.Research output: Other contribution › Net publication - Internet publication › Communication
- Published
Opportunities and challenges for user-generated licensing models in gene-editing
Minssen, Timo, Van Zimmeren, E. & Wested, Jakob, Jul 2018, Harvard Law School's Bill of Health blog.Research output: Other contribution › Net publication - Internet publication › Communication
- Published
Patentability Standards for Follow-on Pharmaceutical Innovation
Holman, C. M., Minssen, Timo & Solovy, E. M., 1 Jun 2018, In: Biotechnology Law Report. 37, 3, p. 131-161 31 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Big Data in the Health and Life Sciences: What Are the Challenges for European Competition Law and Where Can They Be Found?
Minssen, Timo & Schovsbo, Jens Hemmingsen, Jun 2018, Intellectual Property and Digital Trade in the Age of Artificial Intelligence and Big Data. Seuba, X., Geiger, C. & Pénin, J. (eds.). Centre d'études internationales de la propriété intellectuelles (CEIPI), p. 121-130 10 p. (CEIPI / ICTSD Publication Series on Global Perspectives and Challenges for the Intellectual Property System; No. 5).Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- Published
Unlocking the full potential of Open Innovation in the Life Sciences through a classification system
Nilsson, N. & Minssen, Timo, 1 Apr 2018, In: Drug Discovery Today. 23, 4, p. 771-775 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
FAIR DATA SHARING & DATA CARING IN THE DIGITALIZED ERA: ASPIRATIONS, REALITIES & LEGAL CLASHES IN THE HEALTH & LIFE SCIENCES: Abstract of presentation at Stanford Law School
Minssen, Timo, Mar 2018.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
ID: 16150437
Most downloads
-
4338
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2221
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2088
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published